An interventional study of VIVID Brain and No-treatment Control in Visual Fields Hemianopsia and Hemianopsia, Homonymous, sponsored by Nunaps Inc. Completed at 12 sites in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2023-11-13.
Sponsored by Nunaps Inc · Not applicable, Interventional, and Treatment
This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain disease. Half of participants will receive visual perceptual training using the VIVID Brain. The other half will not receive any training because there is no standard treatment for visual field defect caused by brain disease.
63 studies on the registry are indexed under Hemianopsia; 24 are open to participants now.
This study's enrollment of 93 is above the median of 32 across 53 interventional studies indexed under Hemianopsia.
Browse Hemianopsia studies →Nunaps Inc is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
VIVID Brain, 5 times a week for 12 weeks
Device: VIVID Brain
No-treatment is administered during control period.
Other: No-treatment Control
Participants receive visual perceptual training using the VIVID Brain software.
No-treatment is administered during control period.
The sum of improved areas compared to baseline in the whole field
The sum of areas where sensitivity increased by more than 6 dB compared to baseline in the whole field measured by Humphrey visual field test. The improved area ranges between 0 and 2,736 degree\^2, of which larger area indicates better outcome.
Time frame: 12 weeks
The sum of improved areas compared to baseline in the affected hemi-field
The sum of areas where sensitivity increased by more than 6 dB compared to baseline in the affected hemi-field measured by Humphrey visual field test.
Time frame: 12 weeks
Changes in perimetric mean deviation relative to baseline in the whole field
Changes in perimetric mean deviation relative to baseline in the whole field measured by Humphrey visual field test.
Time frame: 12 weeks
Changes in mean total deviation relative to baseline in the affected hemi-field
Changes in mean total deviation relative to baseline in the affected hemi-field measured by Humphrey visual field test.
Time frame: 12 weeks
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nunaps Inc